Janux Therapeutics (JANX) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free JANX Stock Alerts $48.92 -3.02 (-5.81%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Janux Therapeutics Short Interest DataCurrent Short Volume3,300,000 sharesPrevious Short Volume3,440,000 sharesChange Vs. Previous Month-4.07%Dollar Volume Sold Short$188.10 millionShort Interest Ratio / Days to Cover3.2Last Record DateApril 30, 2024Outstanding Shares51,850,000 sharesFloat Size34,560,000 sharesShort Percent of Float9.55%Today's Trading Volume1,031,669 sharesAverage Trading Volume900,884 sharesToday's Volume Vs. Average115% Short Selling Janux Therapeutics ? Sign up to receive the latest short interest report for Janux Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatJANX Short Interest Over TimeJANX Days to Cover Over TimeJANX Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Janux Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,300,000 shares $188.10 million -4.1%9.6%3.2 $57.00 4/15/20243,440,000 shares $178.40 million -8.3%10.0%3.8 $51.86 3/31/20243,750,000 shares $141.19 million +20.6%11.6%5.3 $37.65 3/15/20243,110,000 shares $122.69 million +7.2%9.6%4.6 $39.45 2/29/20242,900,000 shares $140.30 million +18.9%9.2%4.8 $48.38 2/15/20242,440,000 shares $23.18 million -0.4%8.6%6.6 $9.50 Get the Latest News and Ratings for JANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,450,000 shares $20.97 million -1.6%8.6%21.5 $8.56 1/15/20242,490,000 shares $25.27 million -0.8%8.8%20.6 $10.15 12/31/20232,510,000 shares $26.93 million +3.7%8.8%20.3 $10.73 12/15/20232,420,000 shares $25.10 million -5.1%8.5%20.5 $10.37 11/30/20232,550,000 shares $22.26 million +2.4%8.9%23.7 $8.73 11/15/20232,490,000 shares $21.86 million -4.6%8.7%23.5 $8.78 10/31/20232,610,000 shares $16.76 million -3.7%8.7%30.4 $6.42 10/15/20232,710,000 shares $23.69 million -5.9%9.1%31.8 $8.74 9/30/20232,880,000 shares $29.03 million -4.0%9.6%34.5 $10.08 9/15/20233,000,000 shares $29.61 million +1.4%10.0%31.7 $9.87 8/31/20232,960,000 shares $32.56 million +1.7%9.9%29.6 $11.00 8/15/20232,910,000 shares $34.92 million -3.0%9.7%26.4 $12.00 7/31/20233,000,000 shares $42 million +0.3%11.0%20 $14.00 7/15/20232,990,000 shares $37.26 million No Change11.8%20.8 $12.46 6/30/20232,990,000 shares $35.49 million -1.0%13.0%22.9 $11.87 6/15/20233,020,000 shares $39.56 million +4.9%13.1%24 $13.10 5/31/20232,880,000 shares $33.47 million -2.4%12.5%23.6 $11.62 5/15/20232,950,000 shares $35.49 million +0.3%12.8%26.6 $12.03 4/30/20232,940,000 shares $45.04 million +7.3%13.0%42.3 $15.32 4/15/20232,740,000 shares $40.11 million +4.6%12.1%35.7 $14.64 3/31/20232,620,000 shares $31.70 million -1.1%11.8%23.3 $12.10 3/15/20232,650,000 shares $35.64 million +3.9%11.9%22.6 $13.45 2/28/20232,550,000 shares $42.41 million +0.4%11.5%21.5 $16.63 2/15/20232,540,000 shares $43.21 million +8.6%11.4%21.7 $17.01 1/31/20232,340,000 shares $51.97 million +8.8%10.5%19.5 $22.21 1/15/20232,150,000 shares $44.23 million -13.7%9.7%17.5 $20.57 12/30/20222,490,000 shares $32.79 million +4.2%11.3%24.3 $13.17 12/15/20222,390,000 shares $30.35 million -9.5%10.8%30.7 $12.70 11/30/20222,640,000 shares $36.01 million -2.2%12.0%36.8 $13.64 11/15/20222,700,000 shares $44.50 million -21.3%12.2%40.1 $16.48 10/31/20223,430,000 shares $62.01 million No Change15.6%58.7 $18.08 10/15/20223,430,000 shares $44.73 million -0.6%15.6%73.4 $13.04 9/30/20223,450,000 shares $46.71 million +1.8%15.7%63.5 $13.54 9/15/20223,390,000 shares $44.92 million +1.2%15.4%45.1 $13.25The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide JANX Short Interest - Frequently Asked Questions What is Janux Therapeutics' current short interest? Short interest is the volume of Janux Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,300,000 shares of JANX short. 9.55% of Janux Therapeutics' shares are currently sold short. Learn More on Janux Therapeutics' current short interest. What is a good short interest ratio for Janux Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JANX shares currently have a short interest ratio of 3.0. Learn More on Janux Therapeutics's short interest ratio. What is a good short interest percentage for Janux Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.55% of Janux Therapeutics' floating shares are currently sold short. Is Janux Therapeutics' short interest increasing or decreasing? Janux Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 3,300,000 shares, a drop of 4.1% from the previous total of 3,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Janux Therapeutics' float size? Janux Therapeutics currently has issued a total of 51,850,000 shares. Some of Janux Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Janux Therapeutics currently has a public float of 34,560,000 shares. How does Janux Therapeutics' short interest compare to its competitors? 9.55% of Janux Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Janux Therapeutics: IDEAYA Biosciences, Inc. (16.17%), Xenon Pharmaceuticals Inc. (3.70%), Arrowhead Pharmaceuticals, Inc. (7.76%), Amicus Therapeutics, Inc. (9.71%), HUTCHMED (China) Limited (0.26%), Prestige Consumer Healthcare Inc. (3.79%), Ultragenyx Pharmaceutical Inc. (5.59%), Merus (5.76%), ACADIA Pharmaceuticals Inc. (7.28%), MoonLake Immunotherapeutics (14.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Janux Therapeutics stock? Short selling JANX is an investing strategy that aims to generate trading profit from Janux Therapeutics as its price is falling. JANX shares are trading down $3.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Janux Therapeutics? A short squeeze for Janux Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JANX, which in turn drives the price of the stock up even further. How often is Janux Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JANX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: IDYA Short Interest XENE Short Interest ARWR Short Interest FOLD Short Interest HCM Short Interest PBH Short Interest RARE Short Interest MRUS Short Interest ACAD Short Interest MLTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JANX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityHow Biden has already won 2024Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders